# Molecular Properties

## Molecule 1

| Property | Value |
|----------|-------|
| **Canonical SMILES** | O=C(NS(=O)(=O)C)NC1=C(CC1C(=O)Nc1ccccc1C(=O)Nc1ccccc1)C(C)C |
| **Formula** | C23H26N4O5S |
| **MW** | 470.54 |
| **#Heavy atoms** | 33 |
| **#Aromatic heavy atoms** | 12 |
| **Fraction Csp3** | 0.26 |
| **#Rotatable bonds** | 11 |
| **#H-bond acceptors** | 5 |
| **#H-bond donors** | 4 |
| **MR** | 125.99 |
| **TPSA** | 141.85 |

### Lipophilicity

| Property | Value |
|----------|-------|
| **iLOGP** | 2.48 |
| **XLOGP3** | 2.83 |
| **WLOGP** | 3.77 |
| **MLOGP** | 1.58 |
| **Silicos-IT Log P** | 1.42 |
| **Consensus Log P** | 2.42 |

### Water Solubility

| Property | Value |
|----------|-------|
| **ESOL Log S** | -4.08 |
| **ESOL Solubility (mg/ml)** | 3.88e-02 |
| **ESOL Solubility (mol/l)** | 8.25e-05 |
| **ESOL Class** | Moderately soluble |
| **Ali Log S** | -5.47 |
| **Ali Solubility (mg/ml)** | 1.61e-03 |
| **Ali Solubility (mol/l)** | 3.41e-06 |
| **Ali Class** | Moderately soluble |
| **Silicos-IT LogSw** | -6.81 |
| **Silicos-IT Solubility (mg/ml)** | 7.36e-05 |
| **Silicos-IT Solubility (mol/l)** | 1.56e-07 |
| **Silicos-IT class** | Poorly soluble |

### Pharmacokinetics

| Property | Value |
|----------|-------|
| **GI absorption** | Low |
| **BBB permeant** | No |
| **Pgp substrate** | Yes |
| **CYP1A2 inhibitor** | No |
| **CYP2C19 inhibitor** | No |
| **CYP2C9 inhibitor** | Yes |
| **CYP2D6 inhibitor** | No |
| **CYP3A4 inhibitor** | Yes |
| **log Kp (cm/s)** | -7.16 |

### Druglikeness

| Property | Value |
|----------|-------|
| **Lipinski #violations** | 0 |
| **Ghose #violations** | 0 |
| **Veber #violations** | 2 |
| **Egan #violations** | 1 |
| **Muegge #violations** | 0 |
| **Bioavailability Score** | 0.55 |
| **PAINS #alerts** | 0 |
| **Brenk #alerts** | 0 |
| **Leadlikeness #violations** | 2 |
| **Synthetic Accessibility** | 4.28 |
